Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Cantor Fitzgerald
Johnson and Johnson
US Army
Fuji
Healthtrust
UBS
Express Scripts
Argus Health

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,469,015

« Back to Dashboard

Which drugs does patent 6,469,015 protect, and when does it expire?

Patent 6,469,015 protects DENAVIR and is included in one NDA.

This patent has thirty-three patent family members in twenty-seven countries.
Summary for Patent: 6,469,015
Title: Pharmaceutical formulation
Abstract:An oil-in-water topical pharmaceutical formulation or an aqueous formulation for the treatment of virus infections of the skin or mucosa, comprising at least 30% of propylene glycol and solubilized penciclovir.
Inventor(s): Griffiths; Hazel-Ann (Dorking, GB), Goodall; Alan John (Worthing, GB), Oduro-Yeboah; Joshua (Worthing, GB)
Assignee: Novartis International Pharmaceutical Ltd (Hamilton, BM)
Application Number:08/462,257
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 6,469,015

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,469,015

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 197 ➤ Sign Up
African Regional IP Organization (ARIPO) 9000236 ➤ Sign Up
Austria 142880 ➤ Sign Up
Australia 643975 ➤ Sign Up
Australia 7155891 ➤ Sign Up
Canada 2074503 ➤ Sign Up
China 1053547 ➤ Sign Up
China 1056058 ➤ Sign Up
Cyprus 1984 ➤ Sign Up
Germany 69122229 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
UBS
Teva
Express Scripts
US Army
Moodys
Baxter
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot